Daniel Hunter

Daniel joined Exponent in January 2020, having previously worked at Allen & Overy.

Since then, he has been involved in the BBI, Xeinadin, Natara and Chanelle Pharma transactions.

He currently observes on the boards of Vibrant Foods, Gu and Xeinadin.

Born and raised in Cheshire, he has an MA in Law from Oxford University and an MBA from INSEAD.